header4.jpg

Newsroom: Latest News

Here is the new Press Release Title

Nouzilly, March 23, 2022 – New content here

About Igyxos

Igyxos’ mission is to develop new and innovative medical and pharmaceutical technologies in the field of human fertility. Igyxos is involved in all phases of development, from the discovery of promising targets to the identification of potential active compounds such as antibodies. The success of its €7.5 million Series A funding led by Bpifrance, through the FABS funds, alongside with Go Capital Amorçage II and Loire Valley Invest Funds managed by Go Capital and the Emergence Innovation II Fund managed by Sofimac Innovation, will allow Igyxos to develop its lead compound and reach clinical proof of concept. www.igyxos.com.

Press Contacts:

Igyxos

Pierre-Henry Longeray

06 64 28 81 31

 

Marie-Christine Maurel

06 03 34 75 36